Is NOPE or JNJ a better dividend investment in 2026?

NOPE currently yields 23.89% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: NOPE offers higher current income.

What is the dividend yield difference between NOPE and JNJ?

NOPE has a forward dividend yield of 23.89% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 20.53 percentage points.

Home › Compare › NOPE vs JNJ

NOPE vs JNJ: Dividend Comparison 2026

NOPE yields 23.89% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NOPE wins by $72.4K in total portfolio value

INVESTMENT

TIME HORIZON10 years

NOPE

● Live price

23.89%

Share price

$8.37

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$92.4K

Annual income

$10,010.35

Full NOPE calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — NOPE vs JNJ

📍 NOPE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NOPE	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NOPE + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NOPE pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NOPE

Annual income on $10K today (after 15% tax)

$2,030.70/yr

After 10yr DRIP, annual income (after tax)

$8,508.80/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, NOPE beats the other by $7,805.18/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NOPE + JNJ for your $10,000?

NOPE: 50%JNJ: 50%

100% JNJ50/50100% NOPE

Portfolio after 10yr

$56.2K

Annual income

$5,419.06/yr

Blended yield

9.64%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NOPE

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NOPE buys

JNJ buys

No recent congressional trades found for NOPE or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNOPEJNJ

Forward yield	23.89% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$92.4K ✓	$20.0K
Annual income after 10y	$10,010.35 ✓	$827.78
Total dividends collected	$57.3K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: NOPE vs JNJ ($10,000, DRIP)

Year	NOPE Portfolio	NOPE Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$13,089	$2,389.06	$10,676	$355.77	+$2.4K → NOPE
2	$16,928	$2,922.48	$11,407	$389.39	+$5.5K → NOPE
3	$21,645	$3,532.31	$12,198	$426.53	+$9.4K → NOPE
4	$27,381	$4,221.18	$13,056	$467.62	+$14.3K → NOPE
5	$34,289	$4,990.53	$13,987	$513.12	+$20.3K → NOPE
6	$42,529	$5,840.60	$14,998	$563.56	+$27.5K → NOPE
7	$52,277	$6,770.38	$16,098	$619.52	+$36.2K → NOPE
8	$63,714	$7,777.67	$17,295	$681.69	+$46.4K → NOPE
9	$77,033	$8,859.12	$18,599	$750.82	+$58.4K → NOPE
10	$92,436	$10,010.35	$20,022	$827.78	+$72.4K → NOPE

NOPE vs JNJ: Complete Analysis 2026

NOPE — Stock

The fund is an actively-managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by purchasing long positions in securities expected to increase in price and/or taking short positions in securities expected to decline in price. The fund may invest in the securities of U.S. and international exchange-listed large-, mid-, and small-capitalization companies. It is non-diversified.

Full NOPE Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this NOPE vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NOPE vs SCHD NOPE vs JEPI NOPE vs O NOPE vs KO NOPE vs MAIN NOPE vs ABBV NOPE vs MRK NOPE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.